{
    "eid": "2-s2.0-85131102742",
    "title": "SARS-CoV-2 vaccines: Current trends and prospects of developing plant-derived vaccines",
    "cover-date": "2022-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Economics, Econometrics and Finance (all)",
            "@code": "2000",
            "@abbrev": "ECON"
        },
        {
            "@_fa": "true",
            "$": "Business, Management and Accounting (all)",
            "@code": "1400",
            "@abbrev": "BUSI"
        }
    ],
    "keywords": [
        "COVID-19",
        "human health",
        "RNA virus",
        "SARS-CoV-2",
        "vaccines"
    ],
    "authors": [
        "Balamurugan Shanmugaraj",
        "Narach Khorattanakulchai",
        "Waranyoo Phoolcharoen"
    ],
    "citedby-count": 8,
    "ref-count": 118,
    "ref-list": [
        "Incubation period of 2019 novel coronavirus (2019- nCoV) infections among travellers from Wuhan, China, 20 28 January 2020",
        "Architecture of the SARS coronavirus prefusion spike",
        "Plastid molecular pharming I. Production of oral vaccines via plastid transformation",
        "Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice",
        "Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E",
        "COVID-19 Disease due to SARS-CoV-2 (Novel Coronavirus)",
        "Plant-based vaccines for protection against infectious and autoimmune diseases",
        "Plant-made oral vaccines against human infectious diseases\u2014Are we there yet?",
        "Highly immunogenic and protective recombinant vaccine candidate expressed in transgenic plants",
        "Emerging coronaviruses: Genome structure, replication, and pathogenesis",
        "Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR",
        "Cold chain and virus-free oral polio booster vaccine made in lettuce chloroplasts confers protection against all three poliovirus serotypes",
        "A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo",
        "Antigen production in plant to tackle infectious diseases flare up: The case of SARS",
        "Pilot production of SARS-CoV-2 related proteins in plants: A proof of concept for rapid repurposing of indoor farms into biomanufacturing facilities",
        "A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity",
        "Development of an inactivated vaccine candidate for SARS-CoV-2",
        "Nicotiana benthamiana: Its history and future as a model for plant-pathogen interactions",
        "rRT-PCR results of a Covid-19 diagnosed geriatric patient",
        "Novel Wuhan (2019-nCoV) coronavirus",
        "Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry",
        "Production of antibodies in transgenic plants",
        "Severe respiratory syndromes: Travel history matters",
        "COVID-19 vaccine design: The Janus face of immune enhancement",
        "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",
        "Identification of in vivo-interacting domains of the murine coronavirus nucleocapsid protein",
        "Expression of cholera toxin B subunit in transgenic tomato plants",
        "A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)",
        "Chest CT findings in 2019 novel coronavirus (2019-NCoV) infections from Wuhan, China: Key points for the radiologist",
        "Emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2: Biology and therapeutic options",
        "Edible vaccines: Promises and challenges",
        "First plant-made biologic approved",
        "Recombinant receptor binding domain protein induces partial protective immunity in rhesus macaques against Middle East respiratory syndrome coronavirus challenge",
        "The incubation period of coronavirus disease 2019 (CoVID-19) from publicly reported confirmed cases: Estimation and application",
        "Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection",
        "Asymptomatic and symptomatic patients with non-severe coronavirus disease (COVID-19) have similar clinical features and virological courses: A retrospective single center study",
        "RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response",
        "Expression of the human hepatitis B virus large surface antigen gene in transgenic tomato plants",
        "The production of recombinant pharmaceutical proteins in plants",
        "Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): An emerging zoonotic respiratory pathogen in humans",
        "Differential activation of T cell clones stimulated by macrophages exposed to antigen complexed with monoclonal antibodies. A possible influence of paratope specificity on the mode of antigen processing",
        "Molecular pharming-VLPs made in plants",
        "A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial",
        "Recombinant immune complexes as versatile and potent vaccines",
        "Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice",
        "Expression of the rabies virus glycoprotein in transgenic tomatoes",
        "COVID-19: Consider cytokine storm syndromes and immunosuppression",
        "Development of systems for the production of plant-derived biopharmaceuticals",
        "Molecular pharming\u2019s foot in the FDA\u2019s door: Protalix\u2019s trailblazing story",
        "Production of monoclonal antibodies in plants for cancer immunotherapy",
        "Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E",
        "A structural analysis of M protein in coronavirus assembly and morphology",
        "Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes Virus fitness and pathogenesis",
        "Plant-based oral vaccines: Results of human trials",
        "Plant-derived recombinant immune complexes as self-adjuvanting TB immunogens for mucosal boosting of BCG",
        "Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana",
        "Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate\u2014Two randomized Phase II clinical trials in 18 to 49 and 50 years old adults",
        "SARS-CoV-2 vaccine development: Current status",
        "Plant-made dengue virus-like particles produced by co-expression of structural and non-structural proteins induce a humoral immune response in mice",
        "Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp",
        "Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana",
        "Green therapeutic biocapsules: Using plant cells to orally deliver biopharmaceuticals",
        "A perspective on the development of plant-made vaccines in the fight against Ebola virus",
        "Transmission of 2019-NCOV infection from an asymptomatic contact in Germany",
        "Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury",
        "Plant-based vaccines against viruses",
        "Recombinant plant-derived pharmaceutical proteins: Current technical and economic bottlenecks",
        "The increasing value of plant-made proteins",
        "Putting the spotlight back on plant suspension cultures",
        "Critical analysis of the commercial potential of plants for the production of recombinant proteins",
        "Coronavirus envelope protein: Current knowledge",
        "Virus-like particles produced in plants as potential vaccines",
        "Plant molecular farming: A viable platform for recombinant biopharmaceutical production",
        "Emergence of novel coronavirus 2019-nCoV: Need for rapid vaccine and biologics development",
        "Monoclonal antibodies B38 and H4 produced in Nicotiana benthamiana neutralize SARS-CoV-2 in vitro",
        "Development of plant-produced recombinant ACE2-Fc fusion protein as a potential therapeutic agent against SARS-CoV-2",
        "Production of immunogenic VP6 protein of bovine group A rotavirus in transgenic potato plants",
        "Plant-based oral vaccines: Results of human trials",
        "Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes",
        "Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: Implication for development of RBD protein as a viral attachment inhibitor and vaccine",
        "Transgenic plants in the biopharmaceutical market",
        "Need of cost-effective vaccines in developing countries: What plant biotechnology can offer?",
        "Structure, function, and antigenicity of the SARS-CoV-2 spike",
        "The adjuvanticity of an O. volvulus-derived rOv-ASP-1 protein in mice using sequential vaccinations and in non-human primates",
        "Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18-64 years) and older adults (\u226565 years): Two multicentre, randomised phase 3 trials",
        "Analysis of 2019 novel coronavirus infection and clinicalcharacteristics of outpatients: An epidemiological study froma fever clinic in Wuhan, China",
        "Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets",
        "Construction of SARS-CoV-2 virus-like particles by mammalian expression system",
        "Immunogenicity in humans of an edible vaccine for hepatitis B",
        "A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice",
        "Plants as factories for human pharmaceuticals: Applications and challenges",
        "A familial cluster of infection associated with the 2019 novel coronavirus indicating possible person-to-person transmission during the incubation period",
        "Expression and functional evaluation of biopharmaceuticals made in plant chloroplasts",
        "A genomic perspective on the origin and emergence of SARS-CoV-2",
        "Boosted expression of the SARS-CoV nucleocapsid protein in tobacco and its immunogenicity in mice",
        "Therapeutic recombinant protein production in plants: Challenges and opportunities",
        "Potential Applications of Plant Biotechnology against SARS-CoV-2",
        "Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor",
        "Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses",
        "Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants",
        "Development of SARS-CoV-2 vaccines: Should we focus on mucosal immunity?",
        "Will plant-made biopharmaceuticals play a role in the fight against COVID-19?",
        "Plant expression platform for the production of recombinant pharmaceutical proteins",
        "Development of a lateral flow immunoassay strip for rapid detection of IgG antibody against SARS-CoV-2 virus",
        "Establishing a high sensitivity detection method for SARS-CoV-2 IgM/IgG and developing a clinical application of this method"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": []
}